Richard P. Slaughter Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$820K Sell
684
-138
-17% -$141K 0.16% 58
2026
Q1
$756K Sell
822
-72
-8% -$73K 0.16% 58
2025
Q4
$961K Sell
894
-101
-10% -$96.6K 0.2% 57
2025
Q3
$759K Sell
995
-1,170
-54% -$871K 0.16% 65
2025
Q2
$1.69M Buy
2,165
+160
+8% +$124K 0.34% 42
2025
Q1
$1.66M Buy
+2,005
New +$1.67M 0.39% 41

Other funds holding LLY

Richard P. Slaughter Associates's LLY Position: Q2 2026 in Review

Richard P. Slaughter Associates reduced its Eli Lilly (LLY) stake by 17% in Q2 2026, selling an estimated $141K and leaving 684 shares worth $820K. The position accounts for 0.16% of the portfolio, ranked #58.

Richard P. Slaughter Associates first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.69M in Q2 2025. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Richard P. Slaughter Associates held 684 shares of Eli Lilly worth $820K as of Q2 2026.
  • Richard P. Slaughter Associates sold 138 Eli Lilly shares in Q2 2026, an estimated $141K.
  • Eli Lilly made up 0.16% of Richard P. Slaughter Associates's portfolio in Q2 2026, its #58 holding.
  • Richard P. Slaughter Associates first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • Richard P. Slaughter Associates's Eli Lilly position peaked at $1.69M in Q2 2025.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Richard P. Slaughter Associates's 13F filing for Q2 2026, filed 13 Jul 2026.